Diagnostic Impact of Two‐Dimensional Shear Wave Elastography for Liver Fibrosis: A Multicenter Retrospective Study
AIM: Two-dimensional shear wave elastography (2D-SWE) is a non-invasive technique for assessing liver fibrosis. However, its clinical utility has not been fully established. This study evaluated the diagnostic accuracy of 2D-SWE using magnetic resonance elastography (MRE) as the reference standard in a retrospective, multicenter, large-scale cohort. METHODS: A total of 744 patients with chronic liver disease were included in the analysis. The association between 2D-SWE measurements and fibrosis stages determined by MRE was assessed. The correlation between 2D-SWE and MRE values was analyzed, and the diagnostic performance of 2D-SWE was evaluated using receiver operating characteristic (ROC) curve analysis. RESULTS: As 2D-SWE and MRE values were not normally distributed, they were log-transformed (Log-2D-SWE and Log-MRE) for analysis. A strong correlation was observed between Log-2D-SWE and Log-MRE values, with a correlation coefficient of 0.764 (p < 0.001). When 2D-SWE values were stratified according to the histological stages of liver fibrosis (F0-F4), based on MRE data, the corresponding median values were 4.61, 5.63, 6.18, 7.44, and 11.64 kPa, respectively (p < 0.001, Jonckheere-Terpstra test). The areas under the ROC curve (AUROCs) and cutoff values for 2D-SWE were 0.872 and 5.47 kPa for ≥ F1 (n = 285), 0.894 and 5.88 kPa for ≥ F2 (n = 217), 0.931 and 6.48 kPa for ≥ F3 (n = 137), and 0.937 and 7.39 kPa for F4 (n = 81), respectively. In subgroup analyses, AUROCs for detecting ≥ F2, ≥F3, and F4 exceeded 0.78, even among patients with elevated body mass index or advanced hepatic steatosis. CONCLUSIONS: 2D-SWE represents a highly useful and reliable non-invasive modality for assessing of liver fibrosis.
Authors
- Tamami Abe (ORCID: https://orcid.org/0000-0001-8314-7187)
- Reiichiro Kondo (ORCID: https://orcid.org/0000-0002-2769-7392)
- Junko Tanaka (ORCID: https://orcid.org/0000-0002-5669-4051)
- F MORIYASU
- Shigehiro Kokubu (ORCID: https://orcid.org/0000-0002-7436-0151)
- Asako Nogami (ORCID: https://orcid.org/0000-0002-6923-365X)
- Sadanobu Ogawa (ORCID: https://orcid.org/0000-0002-2916-5875)
- Takuma Nakatsuka (ORCID: https://orcid.org/0000-0002-5727-5385)
- Yuichiro Eguchi
- Atsushi Nakajima
- Yasuaki Suzuki
- Masashi Hirooka
- Hiroko Iijima
- Yoichi Hiasa
- Masayoshi Kage
- Ryosuke Tateishi
- Hidekatsu Kuroda
- Tomoyuki Akita
- Hidenori Toyoda
- Hirohisa Yano
- Kento Imajo
- Hirokazu Takahashi
- Takashi Kumada
- Satoshi Oeda
- Takashi Nishimura
- Toshifumi Tada
- Katsutoshi Sugimoto
Institutions
- Kurume University (JP)
- Hiroshima University (JP)
- Hyogo Medical University (JP)
- Tokyo Medical University (JP)
- Saga University (JP)
- Iwate Medical University (JP)
- Ehime Medical Center (JP)
- University of Tokyo Hospital (JP)
- Nayoro City General Hospital (JP)
- Fukui-ken Saiseikai Hospital (JP)
- Ogaki Municipal Hospital (JP)
- Himeji Red Cross Hospital (JP)
- Saiseikai Fukuoka General Hospital (JP)
- Hyogo Prefectural Nishinomiya Hospital (JP)
- Midorigaoka Hospital (JP)
- Ehime University (JP)
- Gifu Kyoritsu University (JP)
- Kobe University (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2026-05-01
- DOI
- https://doi.org/10.1111/hepr.70194
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Canon Medical Systems Corporation